The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

I spent four crazy years writing about Cassava Sciences. Yesterday, the story ended exactly as I and many others knew it ...

Dear Quentin,  I have two sisters who have developed Alzheimer’s disease. My younger sister is actually more severely ...

Alector is kicking off a resource realignment effort that will include a workforce reduction of around 17%. The biotech ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the ...

PORTSMOUTH, Va. (WAVY) – U.S. Senator Tim Kaine applauded the unanimous Senate passage of a bill to help combat Alzheimer’s disease. The bill, also called the BOLD Infrastructure for Alzheimer’s ...

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Nov. 21—John Haldi had early-stage Alzheimer's disease when he began a local Aduhelm drug study in June 2020. For three years ...

In mice, inhibiting protein S-palmitoylation Counteracted accumulation of harmful proteins in neurons and delayed onset and progression of cognitive decline.